Supplementary material and methods

Material for chemical syntheses
Unless otherwise mentioned, all manipulations were performed under argon atmosphere; all reagents were purchased from the following commercial suppliers: Sigma-Aldrich, Acros Organics, Carlo Erba, TCI Europa, Alpha Aesar. DOTA-NHS was purchased from Chematech (Dijon, France) . Anhydrous DMF, anhydrous trimethylamine, anhydrous pyridine were purchased from Acros Organics. THF was dried over a Pure Solv™ Micro Solvent Purification System (Sigma-Aldrich) with an alumina column. Dichloromethane was distilled over calcium hydride. Reactions were monitored by thin layer chromatography (TLC) on silica gel (60 F254; Alugram XTra G/UV254; Macherey-Nagel) or alumina gel (Alumina oxide 60A + F254 neutral; Macherey-Nagel) and visualized with UV light (UV lamp Fisher Bioblock Scientific, 365 nm or 254 nm). Purifications by flash column chromatography were performed on silica gel (Chromagel 60 ACC, 40-63 µm, Carlo Erba Reagents). Purifications on RP18 were conducted on a Combiflash EZ prep system (Teledyne Isco) with a RedispSeP C18 column (250 mm x 20 mm, pores 100 Å, particles 5 µm). Sep-Pak C18 light cartridges were purchased from Waters (Milford, MA, USA). Uncorrected melting points (mp) were measured on an IA9100 Digital Melting Point Apparatus. Infrared spectra (IR) were recorded in the range 4000-440 cm -1 on a Nicolet IS10 with attenuated total reflectance (ATR) accessory. Nuclear magnetic resonance (NMR) spectra were acquired on Bruker AC-200 or 400 operating at 200 or 400 MHz for 1 H NMR and 50 or 100 MHz for 13 C NMR, respectively. All 1 H and 13 C NMR spectra are reported in δ units, parts per million (ppm). Coupling constants were indicated in Hertz (Hz). The following abbreviations are used for spin multiplicity: s = singlet, d = doublet, t = triplet, quint = quintuplet, m =multiplet, and brs = broad singlet. High resolution mass spectra (HRMS) were recorded on an Alliance 2695 (Waters) liquid chromatography coupled with a Q-ToF micro (Waters/Micromass) spectrometer (UCA-START, Clermont-Ferrand, France).
1.2. Access to PEG4, PEG8 and PEG12 aminolinkers 1.2.1. PEG4 derivatives N.B.: Before all reactions, PEGylated compounds were dried twice by co-evaporation with dry toluene (2x40 mL) under reduce pressure. (ethane-2,1-diyl) )bis(oxy))bis(ethane-2,1-diyl) bis(4-methylbenzenesulfonate) (2) 1 To a solution of (1) (18.3 g, 94.21 mmol) in dry freshly distilled CH2Cl2 (120 mL), cooled to 0 °C, TsCl (188.44 mmol) was added portionwise, followed by DMAP (4.71 mmol). After stirring at 0 °C for 10 min, NEt3 (94.21 mmol) was added dropwise. The resulting mixture wad stirred at room temperature for 16 h. Water (80 mL) was added and the resulting solution was extracted with CH2Cl2 (3 × 50 mL) . The combined organic layers were washed with brine (50 mL), dried over MgSO4, filtered and evaporated under reduced pressure. The crude product was purified by column chromatography on silica gel eluted with ethyl acetate to afford compound (2) (90%). 1 H NMR (400 MHz, CDCl3)  2.39 (s, 6H), 12H), 4H), 7.31 (d, 4H, J = 8.5 Hz), 7.75 (d, 4H, J = 8.5 Hz) . These data are in agreement with those of the literature. 1 1.2.1.2. 1-Azido-2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)ethane (3) 1 Compound (2) (40 g, 79.58 mmol) was dissolved in a saturated aqueous solution of NaHCO3 (150 mL) and NaN3 (19.10 mmol) was added. The resulting mixture was stirred at reflux for 20 h. After cooling to RT, the mixture was extracted with CH2Cl2 (3×50 mL), washed with water (40 mL), brine (40 mL), dried over MgSO4, filtered and evaporated under reduced pressure. The crude product was purified by column chromatography on silica gel eluted with ethyl acetate/cyclohexane (5/5, v/v) to afford compound (3) (96%). 1 H NMR (200 MHz, CDCl3)  3.24-3.26 (m, 4H), 3.46-3.58 (m, 12H) . These data are in agreement with those of the literature. 1
((Oxybis
2-(2-(2-(2-Azidoethoxy)ethoxy)ethoxy)ethan-1-amine (4) 1
To a solution of compound (3) (4.28 g, 17.52 mmol) in a 0.65 M aqueous solution of H3PO4 (23 mL) at RT was added dropwise a solution of PPh3 (15.25 mmol) in diethyl ether (20 mL). The resulting mixture was stirred for 20 h. The reaction mixture was extracted with diethyl ether (3×30 mL). KOH (59.05 mmol) was added to the aqueous layer. Traces of ether were evaporated and the aqueous solution was cooled to 4 °C overnight. The precipitate was filtered off. Then, KOH (165.23 mmol) was added to the filtrate and the solution was extracted with diethyl ether (3×60 mL). The combined organic layer were washed with brine (50 mL), dried over MgSO4, filtered and evaporated under reduced pressure. The crude product was dissolved in CH2Cl2 (80 mL) and the solution was washed with 0.65 M H3PO4 (3×50 mL). The combined aqueous solutions were basified with KOH until pH 14, then were extracted with CH2Cl2 (3×60 mL). The combined organic layers were dried over MgSO4, filtered and evaporated under reduced pressure to afford compound (4) (46%) which was used without further purification in the next step. 1 H NMR (200 MHz, CDCl3)  2.75 (brs, 2H), 3.26-3.31 (m, 2H), 3.39-3.62 (m, 12H) . These data are in agreement with those of the literature. 1
tert-Butyl (2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)ethyl)carbamate (5) 2
To a solution of compound (4) (2 g, 9.16 mmol) in CH2Cl2 (85 mL) was added Boc2O (10.99 mmol) portionwise. The reaction mixture was stirred at RT for 24 h, then evaporated under reduced pressure. The crude product was purified by column chromatography on silica gel eluted with ethyl acetate/CH2Cl2/EtOH (70/5/25, v/v/v) To a solution of compound (5) (3 g, 94.2 mmol) in absolute EtOH (120 mL) was added 10% Pd/C (0.3 g) portionwise. The resulting mixture was degassed three times and was stirred under dihydrogen atmosphere (1 bar) for 20 h. The resulting mixture was filtered through a pad of Celite® 545 and the filtrate was evaporated under reduced pressure to dryness to afford compound (6) which was used in the next step without further purification (90%). 1 H NMR (200 MHz, CDCl3)  1.42 (s, 9H), 2.37 (brs, 2H), 2.79-2.87 (m, 2H), 3.27-3.30 (m, 2H), 3.48-3.72 (m, 10H), 5.21 (brs, 1H) . These data are in agreement with those of the literature. 3
PEG8 and PEG12 derivatives
2-(2-(2-(2-Hydroxyethoxy)ethoxy)ethoxy)ethyl 4-methylbenzenesulfonate (7) 4
To a solution of compound (1) (18.3 g, 94.21 mmol) in dry freshly distilled CH2Cl2 (120 mL), cooled to 0 °C, was added TsCl (56.53 mmol) portionwise, followed by NEt3 (70.66 mmol) and DMAP (4.71 mmol) under argon atmosphere. After stirring at 0 °C for 10 min, the resulting mixture was stirred at RT for 16 h. Water (80 mL) was added and the resulting solution was extracted with CH2Cl2 (3×50 mL). The combined organic layers were washed with brine (50 mL), dried over MgSO4, filtered and evaporated under reduced pressure. The crude product was purified by column chromatography on silica gel eluted with ethyl acetate/cyclohexane (3/7, v/v) to afford the ditosylated compound (11 %), followed by elution with pure ethyl acetate to afford the expected compound ( 
2-(2-(2-(2-Azidoethoxy)ethoxy)ethoxy)ethan-1-ol (8) 5
To a solution of compound (7) (5.62 g, 16.13 mmol) in a saturated aqueous solution of NaHCO3 (50 mL), NaN3 (24.19 mmol) was added. The resulting mixture was stirred at reflux for 24 h. After cooling to RT, the mixture was extracted with CH2Cl2 (3×50 mL), washed with water (40 mL), brine (40 mL), dried over MgSO4, filtered and evaporated under reduced pressure. The crude product was purified by column chromatography on silica gel eluted with ethyl acetate to afford compound (8) (81%). 1 H NMR (200 MHz, CDCl3)  3.02 (brs, 1H), 3.50-3.53 (m, 2H), 3.55-3.62 (m, 14H) . These data are in agreement with those of the literature. 5 6 To a solution of compound (8) (8.57 g, 4.30 mmol) in absolute EtOH (120 mL) was added 10% Pd/C (0.86 g) portionwise. The resulting mixture was degassed three times and was stirred under dihydrogen atmosphere (1 bar) for 20 h. The reaction solution was filtered through a pad of Celite® 545 and the filtrate was evaporated under reduced pressure to dryness to afford compound (9) which was used in the next step without further purification (82%). 1 H NMR (200 MHz, CDCl3)  2.88-2.96 (m, 5H), 3.55-3.78 (m, 14H) . These data are in agreement with those of the literature. 6
2-(2-(2-(2-Aminoethoxy)ethoxy)ethoxy)ethan-1-ol (9)
tert-Butyl (2-(2-(2-(2-hydroxyethoxy)ethoxy)ethoxy)ethyl)carbamate (10) 7
To a solution of compound (9) (3.62 g, 18.73 mmol) in CH2Cl2 (75 mL) was added Boc2O (18.73 mmol). The resulting mixture was stirred at RT for 20 h, then was evaporated under reduced pressure. The crude product was purified by column chromatography on silica gel eluted with ethyl acetate/CH2Cl2/EtOH (70/5/25, v/v/v) to afford compound (10) 8 To a solution of compound (10) (2.80 g, 9.56 mmol) in CH2Cl2 (80 mL), cooled to 0 °C, were successively added TsCl (10.52 mmol), DMAP (0.48 mmol) and NEt3 (21.99 mmol). The reaction mixture was stirred at RT for 40 h. A saturated aqueous solution of NaHCO3 was added (30 mL) and the resulting mixture was extracted with dichloromethane (3×20 mL). The combined organic layers were dried over MgSO4, filtered and evaporated under reduced pressure. The crude product was purified by column chromatography on silica gel eluted with CH2Cl2/EtOH (95/5, v/v) to afford compound (11) 
2-(2-(2-(2-Azidoethoxy)ethoxy)ethoxy)ethyl 4-methylbenzenesulfonate (12) 9
To a solution of compound (8) (4.0 g, 18.24 mmol) in CH2Cl2, cooled to 0 °C, were successively added DMAP (1.36 mmol), TsCl (27.36 mmol) and NEt3 (13.68 mmol). The resulting mixture was stirred at reflux for 12 h. After cooling to room temperature, the mixture was poured into water (40 mL), and the organic layer was separated, dried over MgSO4 and evaporated under reduced pressure. The crude product was purified by column chromatography on silica gel eluted with ethyl acetate/cyclohexane (5/5, v/v) to afford compound (12) 1.2.2.5. 23-Azido-3,6,9,12,15,18,21-heptaoxatricosan-1-ol (13) 10 To a solution of compound (1) (8.21 g, 21. 98 mmol) in dry THF, cooled 0 °C, was added NaH (60 % w/w in mineral oil, 10.99 mmol) portionwise. After stirring at 0 °C for 1 h, a solution of compound (12) (21.98 mmol) dissolved in dry freshly distilled THF (10 mL) was added dropwise at 0 °C. The resulting mixture was heated at reflux for 16 h. After cooling to RT, water (40 mL) was added to the reaction mixture and the resulting solution was extracted with ethyl acetate (3×40 mL). The combined organic layers were washed with brine (50 mL), dried over MgSO4, filtered and evaporated under reduced pressure. The crude product was purified by column chromatography on silica gel eluted with CH2Cl2/EtOH (95/5, v/v) to afford compound (13) (71%). 1 H NMR (200 MHz, CDCl3)  3.06 (brs, 1H), 3.34-3.39 (m, 2H), 3.55-3.71 (m, 30H). These data are in agreement with those of the literature. 10 1.2.2.6. 23-Azido-3,6,9,12,15,18,21-heptaoxatricosyl 4-methylbenzenesulfonate (14) 11 To a solution of compound (13) (8.76 g, 15.93 mmol) in CH2Cl2 cooled to 0 °C were successively added DMAP (0.79 mmol), TsCl (19.12 mmol) and NEt3 (19.12 mmol). The resulting mixture was stirred at reflux for 18 h. After cooling to room temperature, the mixture was poured into water (40 mL), and the organic layer was separated, dried over MgSO4 and evaporated under reduced pressure. The crude product was purified by column chromatography on silica gel eluted with ethyl acetate/cyclohexane (5/5, v/v) to afford compound (14) Med. Chem., 2009, 52, 19, 5816-5825. solution was extracted with ethyl acetate (3×30 mL). The combined organic layers were washed with brine (50 mL), dried over MgSO4, filtered and evaporated under reduced pressure. The crude product was purified by column chromatography on silica gel eluted with ethyl acetate/CH2Cl2/EtOH (70/25/5, v/v/v) to afford compound (15) (68%). 1 H NMR (200 MHz, CDCl3)  1.43 (s, 9H), 3.26-3.51 (m, 4H), 3.53-3.75 (m, 28H), 5.12 (brs, 1H); NMR 13 C (125 MHz, CDCl3)  28. 3, 50.5, 69.8, 69.9, 70.0, 70.3, 163. Method B: To a solution of compound (10) (0.125 g, 0.43 mmol) in dry THF cooled to 0 °C, NaH (60 % w/w in mineral oil, 1.28 mmol) was added portionwise. After stirring at 0 °C for 1 h, a solution of compound (12) (0.44 mmol) dissolved in dry THF (10 mL) was added dropwise. The resulting mixture was stirred at RT for 16 h. A saturated aqueous solution of NaHCO3 (30 mL) was added and the resulting solution was extracted with ethyl acetate (3×30 mL). The combined organic layers were washed with brine (50 mL), dried over MgSO4, filtered and evaporated under reduced pressure. The crude product was purified by column chromatography on silica gel eluted with ethyl acetate/CH2Cl2/EtOH (70/25/5, v/v/v) to afford compound (15) 12 To a solution of compound (15) (0.15 g, 0.30 mmol) in a mixture of absolute EtOH and THF (1.8 mL, 2/1, v/v), PPh3 (0.64 mmol) was added portionwise, followed by a 25% aqueous solution of NH4OH (50 µL). The resulting mixture was stirred at RT for 14 h. The reaction mixture was evaporated under reduced pressure. The crude product was dissolved in water (5 mL), and then extracted with CH2Cl2 (3×5 mL). The combined organic layers were dried over MgSO4, filtered and evaporated under reduced pressure. The crude product was purified on a short pad of silica gel eluted with ethyl acetate/EtOH (90/10, v/v), followed by ethyl acetate/CH2Cl2/EtOH/25% aq. NH4OH (75/25/5/0.2, v/v/v/v) to afford compound (16) 2.2.10. tert-Butyl (35-azido-3,6,9,12,15,18,21,24,27,30 ,33-undecaoxapentatriacontyl)carbamate (17) Method A: To a solution of compound (13) (0.75 g, 1.90 mmol) in dry THF cooled to 0 °C, NaH (60% w/w in mineral oil, 5.69 mmol) was added portionwise. After stirring at 0 °C for 1 h, a solution of compound (11) (1.88 mmol) dissolved in dry THF (10 mL) was added dropwise, followed by DMAP (0.19 mmol). The resulting mixture was stirred at RT for 20 h. Water (30 mL) was added and the resulting solution was extracted with ethyl acetate (3×30 mL). The combined organic layers were washed with brine (50 mL), dried over MgSO4, filtered and evaporated under reduced pressure. The crude product was purified by column chromatography on silica gel eluted with ethyl acetate/CH2Cl2/EtOH (70/25/5, v/v/v) to afford compound (17) (63%). 1 H NMR (200 MHz, CDCl3)  1.43 (s, 9H), 3.18-3.89 (m, 48H), 5.14 (brs, 1H); NMR 13 C (125 MHz, CDCl3)  28. 3, 40.5, 52.5, 69.8, 69.9, 71.0, 80.3, 162.2 ; HRMS for C29H58N4O13 m/z [M+H] + calc.: 671.4084; found: 671.4073. Method B: To a solution of compound (10) (0.125 g, 0.43 mmol) in dry THF, cooled to 0 °C, NaH (60% w/w in mineral oil, 1.28 mmol) was added portionwise. After stirring at 0 °C for 1 h, a solution of compound (14) (0.44 mmol) dissolved in dry THF (10 mL) was added dropwise. The resulting mixture was stirred at RT for 16 h. A saturated aqueous solution of NaHCO3 (30 mL) was added and the resulting solution was extracted with ethyl acetate (3×30 mL). The combined organic layers were washed with brine (50 mL), dried over MgSO4, filtered and evaporated under reduced pressure. The crude product was purified on silica gel eluted with ethyl acetate/CH2Cl2/EtOH (70/25/5, v/v/v) to afford compound (17) (17%). 1 H NMR (200 MHz, CDCl3)  1.43 (s, 9H), 3.18-3.89 (m, 48H), 5.14 (brs, 1H). 2.2.11. tert-Butyl (35-amino-3,6,9,12,15,18,21,24,27,30,33-undecaoxapentatriacontyl) 
1.
carbamate (18)
To a solution of compound (17) (0.2 g, 0.30 mmol) in a mixture of absolute EtOH and THF (1.8 mL, 2/1, v/v), PPh3 (0.63 mmol) was added portionwise, followed by 25% aq. NH4OH (50 µL). The resulting mixture was stirred at RT for 14 h. The reaction mixture was evaporated under reduced pressure. The crude product was dissolved in water (5 mL), then extracted with CH2Cl2 (3×5 mL). The combined organic layers were dried over MgSO4, filtered and evaporated under reduced pressure. The crude product was purified on a short pad of silica gel eluted with ethyl acetate/EtOH (90/10, v/v), followed by ethyl acetate/CH2Cl2/EtOH/25% NH4OH (75/25/5/0.2, v/v/v/v) to afford compound (18) 3, 39.7, 40.0, 61.6, 66.4, 70.5, 72.7, 78.6, 156.5 ; HRMS for C21H44N2O9 m/z [M+H] + calc.: 469.3116; found: 169.3119.
Access to TzPEGnDOTA
Compound (19) was synthesized according to published procedure of Rossin et al. 13 Butyl (13,17-dioxo-17-((6-(6-(pyridin-2-yl)-1,2,4 
tert-
,5-tetrazin-3-yl)pyridin-3-yl)amino)-3,6,9-trioxa-12-azaheptadecyl)carbamate (20a)
To a solution of compound (19) (0.125 g, 0.34 mmol) in dry DMF at RT were successively added compound (6) (0.37 mmol), DIPEA (3.42 mmol) and benzotriazol-1yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (0.355 mmol). After stirring at RT for 16 h, the reaction mixture was evaporated under reduced pressure. The crude product was purified by column chromatography on silica gel using MeOH/CH2Cl2 (10/90, v/v) to afford compound (20a) (61%). 5, 28.4, 35.0, 36.2, 39.3, 69.7, 70.0, 70.3, 70.4, 124.3, 125.2, 126.5, 126.8, 132.7, 137.5, 138.5, 142.0, 144.0, 150.2, 150.9, 163.3, 165.5, 171.4 Butyl (25,29-dioxo-29-((6-(6-(pyridin-2-yl)-1,2,4 3,6,9,12,15,18,21- 38 (s, 9H) , 2.05 (quint, 2H, J = 6.9 Hz), 2.33 (t, 2H, J = 6.9 Hz), 2.55 (t, J = 6.9 Hz 2H), 3.41-3.42 (m, 2H), 3.46-3.48 (m, 2H), 3.52-3.58 (m, 28H) , 5.08 (brs, 1H), 6.91 (brs, 1H), 1H), 7.96 (td, J = 7.8, 1.7 Hz, 1H), 8.57 (dd, J = 8.7, 2.4 Hz, 1H), 8.67 (m, 2H), 8.93 (m, 1H) , 9.01 (d, J = 2.1 Hz, 1H), 10.04 (brs, 1H); 13 C NMR (125 MHz, CDCl3)  21. 8, 28.5, 35.2, 36.4, 39.2, 40.6, 69.9, 70.0, 70.1, 70.3, 70.3, 70.4, 70.4, 70.6, 124.1, 125.3, 126.1, 127.1, 137.5, 138.9, 142.3, 143.6, 149.9, 151.0, 163.4, 163.5, 172.5, 173.4 ; HRMS for C39H51N9O11 m/z [M+H] + calc.: 830.4335; found: 830.4334. Butyl (37,41-dioxo-41-((6-(6-(pyridin-2-yl)-1,2,4 3,6,9,12,15,18,21,24,27,30,33 -undecaoxa-36-azahentetracontyl)carbamate (20c) 13 To a solution of compound (19) (0.092 g, 0.25 mmol) in dry DMF were successively added compound (18) (0.28 mmol), DIPEA (2.51 mmol) and benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (0.26 mmol). After stirring at RT for 16 h, the reaction mixture was evaporated under reduced pressure. The crude product was purified by column chromatography on silica gel using MeOH/CH2Cl2 (15/85, v/v) to afford compound (20c) (67%). NMR 1 H (500 MHz, CDCl3)  1.37 (s, 9H), 2.02 (quint, J = 6.9 Hz, 2H), 2.31 (t, J = 6.9 Hz, 2H), 2.55 (t, J = 6.9 Hz, 2H), 3.36-3.43 (m, 2H) 2.3.4.  2,2',2''-(10-(2-Oxo-2-((2-(2-(5-oxo-5-((6-(6-(pyridin-2-yl)-1,2,4,5-tetrazin-3 
tert-
,5-tetrazin-3-yl)pyridin-3-yl)amino)-
tert-
,5-tetrazin-3-yl)pyridin-3-yl)amino)-
-yl)pyridin-3yl)amino)pentanamido)ethoxy)ethyl)amino)ethyl)-1,4,7,10-tetraazacyclododecane-1,4,7triyl)triacetic acid (22a)
To a solution of compound (20a) (0.035g, 5.47 µmoles) in dry CH2Cl2, cooled to -10 °C, was added TFA (4.10 mmol). The resulting mixture was stirred at -10 °C for 2 h. The reaction mixture was evaporated under reduced pressure. The crude product was then co-evaporated twice with acetonitrile (5 mL) and diethyl ether (5 mL). The residue was dissolved in dry DMF solution and DIPEA (0.54 mmol) was added, followed by DOTA-NHS (0.136 mmol). The reaction mixture was stirred at RT for 14 h and then evaporated under reduced pressure. The crude product was purified by preparative HPLC on Combiflash® EZ Prep system (Teledyne Isco) on a RediSep® Prep C18 column (20 mm x 250 mm, 5 µm) eluted at a 15 mL/min flow rate with solvent A (Milli-Q water+0.1% TFA) and solvent B (CH3CN+0.1% TFA) as followed: isocratic elution with 10% solvent B from 0 to 2 min, followed by two successive linear gradients from 10% to 50% solvent B over 16 min then from 50% to 100% solvent B over 1 min, and elution with 100% solvent B over 7 min ( 254 nm), thus providing after lyophilization compound (22a) (RT = 14.38 min, 75%). dissolved in Milli-Q water, so as to reach a 1 µg/µL concentration, and divided into aliquots containing 100 µg of Tz which were lyophilized. These aliquots were stored at -20 °C and were stable up to 6 months (control by analytical HPLC). 2.3.5. 2,2',2''-(10-(2-Oxo-2-((2-(2-(5-oxo-5-((6-(6-(pyridin-2-yl)-1,2,4,5-tetrazin-3-yl) 1,4,7,10-tetraazacyclododecane-1,4,7triyl)triacetic acid (22b) To a solution of compound (20b) (0.018g, 2.26 µmoles) in dry CH2Cl2, cooled to -10 °C, was added TFA (4.10 mmol). The resulting mixture was stirred at -10 °C for 2 h. The reaction mixture was evaporated under reduced pressure. The crude product was then co-evaporated twice with acetonitrile (5 mL) and diethyl ether (5 mL). The residue was dissolved in dry DMF solution and DIPEA (0.46 mmol) was added, followed by DOTA-NHS (5.51 µmoles). The reaction mixture was stirred at RT for 14 h and then evaporated under reduced pressure. The crude product was purified by preparative HPLC on Combiflash® EZ Prep system (Teledyne Isco) on a RediSep® Prep C18 column (20 mm x 250 mm, 5 µm) eluted at a 15 mL/min flow rate with solvent A (Milli-Q water+0.1% TFA) and solvent B (CH3CN+0.1% TFA) as followed: isocratic elution with 10% solvent B from 0 to 2 min, followed by two successive linear gradients from 10% to 50% solvent B over 16 min then from 50% to 60% solvent B over 3 min ( 254 nm), thus providing after lyophilization compound (22b) (RT = 17.02 min, 58%). Afterwards, compound (22b) was dissolved in Milli-Q water, so as to reach a 1 µg/µL concentration, and divided into aliquots containing 100 µg of Tz which were lyophilized. These aliquots were stored at -20 °C and were stable up to 6 months (control by analytical HPLC). 2.3.6. 2,2',2''-(10-(2-Oxo-2-((2-(2-(5-oxo-5-((6-(6-(pyridin-2-yl)-1,2,4,5-tetrazin-3-yl) pyridin-3yl)amino)pentanamido)ethoxy)ethyl)amino)ethyl)-1,4,7,10-tetraazacyclododecane-1,4,7triyl)triacetic acid (22c) 13 To a solution of compound (20c) (0.022 g, 2.22 µmoles) in dry CH2Cl2, cooled to -10°C, was added TFA (1.66 mmol). The resulting mixture was stirred at -10 °C for 2 h. The reaction mixture was evaporated under reduced pressure. The obtained crude product was then co-evaporated twice with acetonitrile (5 mL) and diethyl ether (5 mL). The residue was dissolved in dry DMF and DIPEA (0.46 mmol) was added, followed by DOTA-NHS (5.54 µmoles). The reaction mixture was stirred at RT for 14 h and then evaporated under reduced pressure. The crude product was purified by preparative HPLC on Combiflash® EZ Prep system (Teledyne Isco) on a RediSep® Prep C18 column (20 mm x 250 mm, 5 µm) eluted at a 15 mL/min flow rate with solvent A (Milli-Q water+0.1% TFA) and solvent B (CH3CN+0.1% TFA) as followed: isocratic elution with 10% solvent B from 0 to 2 min, followed by two successive linear gradients from 10% to 50% solvent B over 16 min then from 50% to 60% solvent B over 3 min ( 254 nm), thus providing after lyophilization compound (22c) (RT = 21.05 min, 77%). NMR 1H (500 MHz, DMSO-d6)  1.81 (m, 2H), 2.14 (t, J = 7.4 Hz, 2H ), 2.39 (t, J = 7.4 Hz, 2H ), 3.09 (m, 6H), 3.18 (m, 2H), 3.25 (m, 2H), 30H), 3.89 (m, 2H), 7.65 (m, 1H), 7.89 (m, 1H), 8.06 (td, J = 7.8, 1.7 Hz, 1H), 8.21 (d, J = 8.6 Hz, 1H), 8.32 (dd, J = 8.6, 2.4 Hz, 1H), 8.57 (d, J = 7.8 Hz, 1H), 8.79 (d, J = 4.7 Hz, 1H), 8.93 (d, J = 2.4 Hz, 1H), 10.53 (brs, 1H) ; HRMS for C57H91N13O20 m/z [M+H] + calc.: 639.8324; found: 639.8336.
1.
Afterwards, compound (22c) was dissolved in Milli-Q water, so as to reach a 1 µg/µL concentration, and divided into aliquots containing 100 µg of Tz which were lyophilized. These aliquots were stored at -20 °C and were stable up to 6 months (control by analytical HPLC). -1-4) 2.1. Materials for radiolabeling [ 177 Lu]Lutetium solution was purchased from ITG (Germany) as a [ 177 Lu]LuCl3 solution in 0.04 M aq. HCl. Water was distilled and deionized (18 MΩ/cm) by means of a Milli-Q water filtration system (Millipore). The labeling buffers were treated with Chelex-100 resin (BioRad Laboratories) overnight, then filtered through a "rapid flow" corning with a PES membrane (Thermofisher) and stored at 4 °C. ITLC-SG plates were purchased from Agilent Technologies. ITLC-SG were performed with citrate mobile phase (0.025 M, pH 5) and analyzed with Minigita DUAL radio-TLC scanner. Mobile phase (100 mL) was made up from a combination of citric acid (3.45 g) and sodium citrate (6.94 g) in MilliQ water. Each radiolabeling reaction was monitored by ITLC-SG (free 177 Lu migrated to the solvent front while [ 177 Lu]Lu-Tz derivative remained at the baseline). The purifications by semi-preparative reversed phase-high pressure liquid chromatography (RP-HPLC) were performed on a Perkin Elmer system consisting of a Flexar LC autosampler, a series 200 pump, a Peltier column oven, a vacuum degasser and a PDA and GabiStar Raytest detectors. Semi-preparative RP-HPLC purifications were carried out on a Waters SymmetryPrep TM C18 column (7.8 mm × 300 mm, 7 µm) using the following conditions: flow rate: 2 mL/min, eluent A (Milli-Q water+0.1% TFA), eluent B (CH3CN+0.1% TFA) and detection wavelengths set at 254 and 330 nm. (1) For TzPEG4 derivative, the elution starts with 10% eluent B (0 to 0.5 min), followed by two linear gradients, firstly 10% to 22% eluent B from 0.5 to 20 min, and secondly from 22% to 100% eluent B over 5 min, an isocratic elution with 100% B for 4 min, and finally returned to 10% B over 0.5 min.
Radiolabeling of TzPEGnDOTA (Tz
(2) For TzPEG8 derivative, the elution begins with 20% eluent B from 0 to 2 min, followed by two successive linear gradients, firstly from 20% to 50% B over 23 min, and secondly from 50% to 100% B over 5 min; 100 % B is kept for 30 to 35 min, and finally returned to 20 % B for 35 to 40 min. Analytical RP-HPLC analyses were performed on an Agilent series 1100 HPLC system equipped with an online degasser, a quaternary pump, an automatic sampler, a DAD detector and coupled to a 500TR series (ULTIMO-FLO TM ). Analytical RP-HPLC analyses were carried out on an Agilent Zorbax extend C18 column (4.6 mm × 150 mm, 5 µm) using the following conditions: analysis time: 20 min, flow rate: 1 mL/min, eluent A (Milli-Q water+0.1% TFA), eluent B (CH3CN+0.1% TFA) and detection wavelengths set at 254 nm and 330 nm. The elution program for TzPEG4 derivative starts with an isocratic elution with 25% eluent B for 3.5 min, followed by a linear gradient from 25% to 50% eluent B over 3.5 min and an isocratic elution with 50% eluent B for 13 min. The optimized elution program for TzPEG8 or TzPEG12 derivatives consists of an isocratic elution with 5% eluent B for 3.5 min, followed by a linear gradient from 5% to 50% eluent B for 3.5 min, and ends with an isocratic elution with 50% B for 13 min. The molar activity (Am) was calculated as following [(%radiochemical purities)/(numbers of moles of cold compound)]*radioactivity, where numbers of moles and radioactivity were expressed in µmol and GBq, respectively. For method A, number of moles of "cold compound" was determined using calibration curve by integrating the corresponding peak detected by UV obtained by analytical chromatography RP-HPLC. The radioactivity corresponds to the radioactivity injected into HPLC. For Method B, number of moles of "cold compound" refers to the initial quantity of precursor and radioactivity corresponds to the final radioactivity after formulation.
Radiolabeling of TzPEGnDOTA derivatives
Method A : To a solution of TzPEGnDOTA derivative (Tz-1-3) (100 µg) in NaOAc buffer (0.025 M, pH 7.0, 100 µL) was added a suitable amount of [ 177 Lu]LuCl3 in 0.04 M HCl (40-500 MBq) and the reaction mixture was heated at 50 °C until completion of the reaction (20 min, ITLC monitoring). The reaction mixture was purified by semi-preparative (radio)-RP-HPLC as mentioned above. The collected radiotracer fraction was evaporated under reduced pressure. The residue was diluted with Milli-Q water (20 mL) and purified by adsorption on a Sep-Pak C18 light cartridge. Elution with 0.6 mL of EtOH followed by concentration under reduced pressure afforded the desired radiotracer which was then formulated in sterile isotonic saline. The final solution contained less than 10 % of EtOH (v/v). The identity and radiochemical purity of radiotracer was confirmed by analytical radio-RP-HPLC. Molar activity (MA) was determined on the basis of a UV/mass calibration curve carried out under analytical radio-RP-HPLC conditions using chromatograms recorded at 330 nm.
Method B :
To a solution of TzPEGnDOTA derivative (Tz-1-4) (25µL of 100 µg/100 µL aliquot in DMSO) in NaOAc buffer (0.25 M, pH 5.5, 200 μL) was added a suitable amount of [ 177 Lu]LuCl3 in 0.04 M HCl (40-500 MBq) and the reaction mixture was kept at RT until completion of the reaction (10 min, ITLC). The reaction mixture was then diluted with Milli-Q water (20 mL) and purified by adsorption on a Sep-Pak C18 light cartridge (Waters, Milford, MA, USA). Elution with 0.6 mL of ethanol followed by concentration under reduced pressure provided the desired radiotracer which was then formulated in sterile isotonic saline. The final solution contained less than 10 % of EtOH (v/v). The identity and radiochemical purity of radiotracer were confirmed by analytical radio-RP-HPLC. Molar activity (MA) was determined on the basis of a UV/mass calibration curve carried out under analytical radio-RP-HPLC conditions using chromatograms recorded at 330 nm.
TzPEG4DOTA-[ 177 Lu] ([ 177 Lu]Lu-Tz-1)
Method A: retention time for semi-preparative purification (Rt = 14.38 min); retention time for analytical control (Rt = 10.1 min); RCY = 60-80% (uncorrected); radiochemical purity: 98%; Am > 8 GBq/µmol. Method B: retention time for analytical control (Rt = 10.1 min); RCY = 79%; radiochemical purity > 99%; MA = 12.2 GBq/µmol.
TzPEG8DOTA-[ 177 Lu] ([ 177 Lu]Lu-Tz-2)
Method A: retention time for semi-preparative purification (Rt = 17.02 min); retention time for analytical control (Rt = 13.1 min); RCY = 36%, radiochemical purity: 28%; Am = nd Method B: retention time for analytical control (Rt = 13.1 min); RCY = 89%; radiochemical purity: 99%; Am = 9.3 GBq/µmol Supplementary Figure S2 : Control of the tumor uptake in mice and the tumor growth medians of the different groups after mice randomization using bioluminescence imaging.
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